INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 415m ago
House PTR15m ago
SEC 13F14m ago
Robinhood Chain14m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
GL
Gravelle Michael LEVP, General Counsel & Corp S
FGF&G Annuities & Life, Inc.
Grant or award
A—
9,194 sh
Nov 10, 2025Nov 13, 2025
Page 1815 of 1855
← PrevNext →
traded Nov 10, 2025
+3d
SEC Form 4

Evidence

23
FP
Foley William P IiDirector, Executive Chairman
FGF&G Annuities & Life, Inc.
Grant or award
A—
199.2K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

23
MD
Martinez DouglasDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
6,436 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

23
FA
Fernandez Jose ADirector, Co-Chief Operating Officer
STEPStepStone Group Inc.
Open-market sale · 10b5-1 plan
SELL$3.62M
57.8K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

23
WJ
Walcott Wanjiku JuanitaChief Legal & Bus Affairs Ofc.
PINSPINTEREST, INC.
Open-market sale · 10b5-1 plan
SELL$1.99M
74.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

23
DW
Doka Celina J. WangDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
6,436 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

23
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Option exercise
M$628K
44.1K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

23
QR
Quirk Raymond RDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
6,436 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

23
PL
Punjabi LeenaEVP, Chief Investment Officer
FGF&G Annuities & Life, Inc.
Grant or award
A—
21.9K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

23
RJ
Rubinstein JonathanDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
900 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

22
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$4.40M
36.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

22
MP
Melwani PraveerCFO and Treasurer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$450K
10.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

22
RM
Richard MarkPresident - Western Hemisphere
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$4.44M
160.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

22
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$450K
10.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

22
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$2.13M
17.2K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

21
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$556K
2,913 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Option exercise
M—
15.0K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

21
SC
Schwartz ChristinaSee Remarks
OPENOpendoor Technologies Inc.
Grant or award
A—
400.6K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Option exercise
M—
44.1K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
CS
Cheney Kirk SterlingEVP, GC and Corp Secy
PNTGPennant Group, Inc.
Option exercise
M—
3,800 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion
C—
286.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
OM
Omer MatthewCFO
BZFDBuzzFeed, Inc.
Option exercise
M—
1,667 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Option exercise
M—
15.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

21
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M$18K
100.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

20
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Option exercise
M$127K
10.0K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

20
CS
Cheney Kirk SterlingEVP, GC and Corp Secy
PNTGPennant Group, Inc.
Option exercise
M$57K
3,800 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

20
TH
Telman Deborah HEVP, Corporate Affairs & GC
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M$2.18M
36.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

19
DM
Durham MarkChief Accounting Officer
GTLSCHART INDUSTRIES INC
Tax withholding
F$24K
117 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

19
RD
Rood John DDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
6,436 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

19
NJ
Nolan Michael JosephDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
6,436 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

19
AK
Ammerman Douglas KDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
6,436 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

18
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Gift
G—
298 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

18
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Option exercise · 10b5-1 plan
M$9.69M
417.8K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

17
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion
C—
286.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

17
RU
Rubin UriChief Technology Officer
PLTKPlaytika Holding Corp.
Grant or award
A—
125.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

17
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Option exercise
M—
2,742 sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

17
AD
Arroyo DavidCLO
BZFDBuzzFeed, Inc.
Option exercise
M—
25.1K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

17
BR
Befumo RandyINTERIM CFO
BSLKBolt Projects Holdings, Inc.
Grant or award
A—
17.7K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

17
HW
Henderson Joseph Sean-WalshChief Accounting Officer
BKKTBakkt, Inc.
Open-market sale
SELL$3,634
169 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

17
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Option exercise
M—
6,933 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence